Tumor cells and tumor-infiltrating CD8+ T lymphocytes compete for glucose, and the high glucose consumption of active tumor cells changes the metabolic microenvironment of T cells and inhibits the production of IFN-γ, thus promoting tumor progression and immune escape 17. This evidence concerns the gene CD8A and neoplasm.